- 1. (-)-Phenylisopropylmethylpropynylamine
- [The hydrochloride salt form of selegiline, a levorotatory acetylenic derivative of phenethylamine with antiparkinsonian effect. As a selective monoamine oxidase (MAO) inhibitor, selegiline has the greatest affinity for type B MAO, found mainly in the brain. Selegiline is converted by MAO B to an active moiety, which binds irreversibly at the active site of the enzyme's cofactor FAD (flavin adenine dinucleotide) molecule. This prevents the oxidative deamination of catecholamines and serotonin by MAO B, and leads to an increase in these neurotransmitters' activities resulting in improved motor function. In addition, this agent may inhibit re-uptake of dopamine by the neuron and prolong dopamine activity. ( NCI )] (UMLS (NCI) C0700467) =Organic Chemical; Pharmacologic Substance =l-Deprenyl;
=SELEGILINE HYDROCHLORIDE 5 MG;
| - 36. phenone
- [ ] (UMLS (CSP) C0597208) =Organic Chemical ;
=cyclic ketone;
|
- 2. 1,10-(1,2-Phenylene)pyrene
- [A yellowish, aromatic hydrocarbon consisting of six fused rings and produced by the incomplete combustion of organic matter. Indene[1,2,3-cd]pyrene is primarily found in certain foods, gasoline and diesel exhaust, cigarette smoke, coal tar and coal tar pitch, soot and petroleum asphalt. This substance is used only for research purposes. Indene[1,2,3-cd]pyrene is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0063458) =Organic Chemical; Pharmacologic Substance; Hazardous or Poisonous Substance
| - 37. Phenothiazine
- [3-ring structure of two benzene rings joined by a sulfur and a nitrogen atom; an important class of antipsychotic and other drugs which act by disrupting monoamine transmitter systems. ( CSP )] (UMLS (NCI) C0031436) =Organic Chemical; Pharmacologic Substance ;
=Heterocyclic Compounds, 3-Ring;
thiazine =2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine;
1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI);
2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine;
PROMAZINE;
THIORIDAZINE;
2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine;
ethopropazine;
1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI);
MESORIDAZINE;
METHOTRIMEPRAZINE;
Azul de Metileno;
4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol;
PIPERACETAZINE;
2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine;
PROMAZINE;
PROMETHAZINE;
PROPIOMAZINE;
THIETHYLPERAZINE;
THIORIDAZINE;
10-(3-(4-Methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-10H-phenothiazine;
TRIFLUPROMAZINE;
TRIMEPRAZINE;
acetophenazine;
METHDILAZINE;
MORICIZINE |
- 3. 1,4-Phenylenebis(methylene)selenocyanate
- (UMLS (NCI) C0167369) =Organic Chemical; Pharmacologic Substance ;
| - 38. phenotype
- [the entire physical, biochemical, and physiological makeup of an individual as determined both genetically and environmentally; also, any one or any group of such traits. ( CSP )] (UMLS (CSP) C0031437) =Organism Attribute =Genetics;
=autosomal dominant trait;
autosomal recessive trait;
sex chromosome linked trait |
- 4. 1-phenyl-2-diethyl-amino-1-propanone Hydrochloride
- [A sympathomimetic amine structurally similar to amphetamine with anorexiant activity. Diethylpropion hydrochloride stimulates the central nervous system and increases the release of norepinephrine and dopamine from nerve terminals and inhibits their uptake. This suppresses appetite, increases motor activity, causes euphoria, mental alertness and excitement. This drug may also cause an increase in heart rate and blood pressure. Diethylpropion hydrochloride is used in the treatment of obesity. ( NCI )] (UMLS (NCI) C0282133) =Organic Chemical; Pharmacologic Substance ;
=DIETHYLPROPION;
=DIETHYLPROPION HYDROCHLORIDE 75 MG;
DIETHYLPROPION HYDROCHLORIDE 25 MG | - 39. phenoxyacetate
- [ ] (UMLS (CSP) C0031440) =Organic Chemical =glycolate;
=[2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic Acid |
- 5. 1-Phenyl-Methyl-2-Piperazinyl-1H-Benzimidazole Hydrochloride
- [A drug that prevents or reduces nausea and vomiting. ( NCI )] (UMLS (NCI) C0758799) Lerisetron =Organic Chemical; Pharmacologic Substance ;
| - 40. PHENPROCOUMON
- [Coumarin derivative that acts as a long acting oral anticoagulant. ( MSH )] (UMLS (NCI) C0031444) =Organic Chemical; Pharmacologic Substance ;
=4-Hydroxycoumarins;
[BL100] ANTICOAGULANTS =PHENPROCOUMON 3 MG |
- 6. 2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)-
- [A phenazine dye with anti-mycobacterial and anti-inflammatory activity. The exact mechanism through which clofazime exerts its effect is unknown. However, it binds preferentially to mycobacterial DNA, thereby inhibiting DNA replication and cell growth. Clofazimine has a slow bactericidal effect on Mycobacterium leprae and is active against various other Mycobacteria. ( NCI )] (UMLS (NCI) C0008996) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =phenazine;
[AM900] ANTI-INFECTIVES, OTHER =CLOFAZIMINE 50 MG;
| - 41. PHENSUXIMIDE
- (UMLS (NCI) C0070592) =Organic Chemical; Pharmacologic Substance ;
=[CN400] ANTICONVULSANTS;
succinimide |
- 7. 2-Phenyl-1,3-propanediol Dicarbamate
- [A propanediol compound with anticonvulsant and antiepileptic properties. Although the exact mechanism of action is unknown, Felbamate may be an antagonist at the strychnine-insensitive glycine-recognition site of the N-methyl-D-aspartate (NMDA) receptor-ionophore complex, thereby blocking the effects of the excitatory amino acids, suppressing neuronal firing, and preventing seizure activity. Felbamate also has weak inhibitory effects on gamma-aminobutyric acid (GABA) receptor binding sites which may contribute to its inhibitory effect on neuronal excitatory. ( NCI )] (UMLS (NCI) C0060135) =Organic Chemical; Pharmacologic Substance =[CN400] ANTICONVULSANTS;
propanediol =felbamate 120 MG/ML;
FELBAMATE 600 MG;
FELBAMATE 400 MG;
| - 42. phentermine
- [central nervous system stimulant and sympathomimetic with actions and uses similar to dextroamphetamine; used in the treatment of obesity. ( CSP )] (UMLS (CSP) C0031447) =Organic Chemical; Pharmacologic Substance ;
=Amfetamine;
[CN801] AMPHETAMINES;
[GA750] APPETITE SUPPRESSANTS;
[GA751] CENTRALLY-ACTING APPETITE SUPPRESSANTS =MEPHENTERMINE;
Phentermine HCl;
PHENTERMINE RESIN COMPLEX;
Phentermine HCl;
PHENTERMINE RESIN COMPLEX |
- 8. 2-Phenylethyl 3-(3,4-dihydroxyphenyl)-2-propenoate
- (UMLS (NCI) C0054434) =Organic Chemical; Pharmacologic Substance ;
| - 43. Phentermine HCl
- [The hydrochloride salt form of phentermine, a sympathomimetic amine with central nervous system (CNS) stimulant and appetite depressant properties. Phentermine hydrochloride stimulates the release of norepinephrine and dopamine from nerve endings and blocks the reuptake of these monoamines at the neuronal junctions, resulting in CNS stimulation and metabolic effects, including appetite-suppression, decreased gastric acid secretion and increased blood pressure. ( NCI )] (UMLS (NCI) C0282304) =Organic Chemical; Pharmacologic Substance =phentermine;
=PHENTERMINE HYDROCHLORIDE 15 MG;
PHENTERMINE HYDROCHLORIDE 37.5 MG;
PHENTERMINE HYDROCHLORIDE 30 MG;
PHENTERMINE HYDROCHLORIDE 18.75 MG;
PHENTERMINE HYDROCHLORIDE 8 MG |
- 9. 2-Phenylethylhydrazine Hydrogen Sulphate
- [A hydrazine derivative and a potent non-selective monoamine oxidase (MAO) inhibitor with anxiolytic and antidepressant properties. Phenelzine sulfate irreversibly binds to MAO, thereby blocking the oxidative deamination of monoamines resulting in an increased concentration of biogenic amines and a concurrent decrease in catabolism of monoamine neurotransmitters, norepinephrine and serotonin, in the brain. In addition, through its primary metabolite phenylethylidenehyrazine (PEH), phenelzine causes elevated GABA levels in the caudate-putamen and nucleus accumbens thereby exerting its anxiolytic effects. ( NCI )] (UMLS (NCI) C0031393) =Organic Chemical; Pharmacologic Substance ;
=PHENELZINE;
=PHENELZINE SULFATE 15 MG | - 44. phenylacetate
- [ ] (UMLS (CSP) C0031452) =Organic Chemical =Acids, Carbocyclic;
phenylcarboxylate =3,4 dihydroxyphenylacetate;
homovanillate;
chlorophenoxyacetate;
CYCLOPENTOLATE;
2-[(2,6-Dichlorophenyl)amino]benzeneacetic Acid;
Diphenylacetic Acids;
alpha-Phenyl-2-piperidineacetic Acid Methyl Ester;
phenylacetic acid;
GUANFACINE |
- 10. 3-Phenyl-1H-naphtho[2,1-b]pyran-1-one
- [A polycyclic aromatic hydrocarbon that consists of a flavone group attached to a benzene ring. Beta-naphthoflavone is an inducer of the hepatic cytochrome p450 CYP1A1 and CYP1A2. ( NCI )] (UMLS (NCI) C0053490) =Organic Chemical; Pharmacologic Substance ;
| - 45. phenylalaninase
- [An enzyme of the oxidoreductase class that catalyzes the formation of L-TYROSINE, dihydrobiopterin, and water from L-PHENYLALANINE, tetrahydrobiopterin, and oxygen. Deficiency of this enzyme may cause PHENYLKETONURIAS and PHENYLKETONURIA, MATERNAL. EC 1.14.16.1. ( MSH )] (UMLS (CSP) C0031456) =Amino Acid, Peptide, or Protein; Enzyme ;
=Oxygenase;
|
- 11. 3-Phenylacetylamino-2, 6-piperidinedione
- [A piperidinedione antineoplaston with potential antineoplastic activity. Antineoplaston A10 was originally isolated from human urine but is now synthetically derived. This agent intercalates into DNA, resulting in cell cycle arrest in G1 phase, reduction of mitosis, and decreased protein synthesis. Antineoplaston A10 may also inhibit ras-oncogene expression and activate tumor suppressor gene p53, leading to cell differentiation and apoptosis. (NCI04) ( NCI )] (UMLS (NCI) C0052080) =Organic Chemical; Pharmacologic Substance ;
| - 46. phenylalanine
- [essential aromatic amino acid that is a precursor of melanin, dopamine, norepinephrine and thyroxine. ( CSP )] (UMLS (CSP) C0031453) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance =Amino Acids, Cyclic;
Amino Acids, Essential;
primary aminoacid;
Inactive Ingredient Preparations =dihydroxyphenylalanine;
4-[bis(2-chloroethyl)amino]-L-phenylalanine;
A 4166;
VIVONEX T.E.N. POWDER,PKT,80.4GM;
PHENYLALANINE 500 MG;
PHENYLALANINE 0.32 GM;
PHENYLALANINE 0.48 GM;
PHENYLALANINE 1.04 MG/ML;
PHENYLALANINE 1.26 MG/ML;
PHENYLALANINE 1.49 MG/ML;
PHENYLALANINE 10.4 MG/ML;
PHENYLALANINE 100 MG/100ML;
PHENYLALANINE 154 MG/100ML;
PHENYLALANINE 155 MG/100ML;
PHENYLALANINE 17 MG;
PHENYLALANINE 170 MG;
PHENYLALANINE 2.09 MG/ML;
PHENYLALANINE 2.28 MG/ML;
PHENYLALANINE 2.53 MG/ML;
PHENYLALANINE 2.98 MG/ML;
PHENYLALANINE 217 MG;
PHENYLALANINE 22.25 MG;
PHENYLALANINE 220 MG/100ML;
PHENYLALANINE 290 MG/100ML;
PHENYLALANINE 3.1 MG/ML;
PHENYLALANINE 3.8 MG/ML;
PHENYLALANINE 30 MG/5ML;
PHENYLALANINE 300 MG/100ML;
PHENYLALANINE 310 MG;
PHENYLALANINE 340 MG;
PHENYLALANINE 340 MG/100ML;
PHENYLALANINE 36 MG/GM;
PHENYLALANINE 380 MG;
PHENYLALANINE 4.27 MG/ML;
PHENYLALANINE 4.8 MG;
PHENYLALANINE 440 MG/100ML;
PHENYLALANINE 447 MG/100ML;
PHENYLALANINE 480 MG/100ML;
PHENYLALANINE 490 MG;
PHENYLALANINE 526 MG;
PHENYLALANINE 526 MG/100ML;
PHENYLALANINE 560 MG;
PHENYLALANINE 560 MG/100ML;
PHENYLALANINE 7.9 MG/ML;
PHENYLALANINE 726 MG/100ML;
PHENYLALANINE 825 MG;
PHENYLALANINE 880 MG |
- 12. 4-Phenylbutyric Acid
- (UMLS (NCI) C0170531) =Organic Chemical
| - 47. phenylalanine analog
- [synthetic or natural compound which resembles phenylalanine in structure and/or function. ( CSP )] (UMLS (CSP) C0597209) =Amino Acid, Peptide, or Protein ;
=aminoacid analog;
=fenclonine |
- 13. PHENACEMIDE
- (UMLS (NCI) C0070525) =Organic Chemical; Pharmacologic Substance ;
=[CN400] ANTICONVULSANTS;
CARBAMIDE | - 48. phenylalanine free
- [Phenylketonuria diet. ( HL7V3.0 )] (UMLS (HL7) C1550574) =Intellectual Product =Diet;
|
- 14. phenanthrene
- [ ] (UMLS (CSP) C0031367) =Organic Chemical ;
=carbopolycyclic compound;
| - 49. Phenylalanine Metabolism
- [The chemical reactions and pathways involving L-phenylalanine, the levorotatory isomer of 2-amino-3-phenylpropanoic acid. [GOC:go_curators] ( GO )] (UMLS (NCI) C1327004) Phenylalanine Metabolism Pathway;
=Molecular Function |
- 15. phenanthridine
- [ ] (UMLS (CSP) C0031369) =Organic Chemical ;
=nitrogenous heterocyclic compound;
=ethidium | - 50. phenylalaninemia
- [group of autosomal recessive disorders marked by a deficiency of the hepatic enzyme phenylaline hydroxylase or less frequently by reduced activity of dihydropteridine reductase. ( CSP )] (UMLS (CSP) C0031485) =Disease or Syndrome ;
=Amino Acid Metabolism, Inborn Errors;
Arrieration mentale =Phenylketonuria, Maternal |
- 16. phenanthroline
- [ ] (UMLS (CSP) C0031370) =Organic Chemical ;
=nitrogenous heterocyclic compound;
| - 51. phenylalkane
- [ ] (UMLS (CSP) C0597211) =Organic Chemical ;
|
- 17. Phenaphthazine
- (UMLS (NCI) C0068806) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
| - 52. phenylalkanol
- [ ] (UMLS (CSP) C0597212) =Organic Chemical ;
|
- 18. phenazine
- [3 ring aromatic structure consisting of 2 benzene rings bridged by ortho nitrogen heteroatoms; used in dyes and larvicides; do not confuse with Phenazine, the drug trade name. ( CSP )] (UMLS (CSP) C0031375) =Organic Chemical ;
=Heterocyclic Compounds, 3-Ring;
nitrogenous heterocyclic compound =2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)- | - 53. phenylalkoxyalkylamine
- [ ] (UMLS (CSP) C0597213) =Organic Chemical ;
=phenylalkylamine;
=atenolol;
DIPHENHYDRAMINE;
FLUOXETINE;
GALLAMINE TRIETHIODIDE;
|
- 19. PHENAZOPYRIDINE
- [A synthetic pyridine derivative anesthetic, Phenazopyridine is used as a local anesthetic in urinary tract disorders to relieve pain of lower urinary-tract irritation, as in cystitis, urethritis or prostatitis. Compatible with relief of pain and discomfort in antibacterial therapy, its use is limited however due to toxicity (primarily blood disorders) and potential carcinogenicity. (NCI04) ( NCI )] (UMLS (NCI) C0031379) =Organic Chemical; Pharmacologic Substance =aminopyridine;
[GU100] ANALGESICS, URINARY =2,6-Diamino-3-(phenylazo)-pyridine Hydrochloride | - 54. phenylalkylamine
- [ ] (UMLS (CSP) C0597214) =Organic Chemical ;
=cyclic amine;
=benzylamine;
METHADONE;
Phenethylamines;
phenolic amine;
phenylalkoxyalkylamine |
- 20. Phencarbamide
- (UMLS (NCI) C0603740) =Organic Chemical; Pharmacologic Substance
| - 55. phenylamide
- [ ] (UMLS (CSP) C0597215) =Amino Acid, Peptide, or Protein ;
=amide;
=4-Hydroxyacetanilide;
(E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide;
.omega.-Diethylamino-2,6-dimethylacetanilide;
PROCAINAMIDE;
cis-4-Amino-5-Chloro-N-(1-(3- (p-fluorophenoxy)propyl)-3-methoxy-4- piperidyl)-o-Anisamide;
p aminohippurate;
|
- 21. PHENDIMETRAZINE
- (UMLS (NCI) C0070549) =Organic Chemical; Pharmacologic Substance ;
=morpholine;
[GA751] CENTRALLY-ACTING APPETITE SUPPRESSANTS =(2S,3S)-3,4-Dimethyl-2-phenylmorpholine L-(+)-tartrate(1:1);
PHENDIMETRAZINE HYDROCHLORIDE;
(2S,3S)-3,4-Dimethyl-2-phenylmorpholine L-(+)-tartrate(1:1);
PHENDIMETRAZINE HYDROCHLORIDE;
PHENDIMETRAZINE 35 MG | - 56. PHENYLBUTAZONE
- [A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. ( MSH )] (UMLS (NCI) C0031463) =Organic Chemical; Pharmacologic Substance ;
=Pyrazole Compound;
[MS102] NONSALICYLATE NSAIS, ANTIRHEUMATIC;
TO BE DELETED INGREDIENT PREPARATIONS;
=OXYPHENBUTAZONE;
3,5-Pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)-;
|
- 22. PHENELZINE
- [monoamine oxidase inhibitor used to treat depression and phobic disorders. ( CSP )] (UMLS (NCI) C0031392) =Organic Chemical; Pharmacologic Substance ;
=[CN600] ANTIDEPRESSANTS;
hydrazine;
MAO inhibitor;
[CN602] MONOAMINE OXIDASE INHIBITOR ANTIDEPRESSANTS =2-Phenylethylhydrazine Hydrogen Sulphate | - 57. phenylbutyrate
- [cytostatic, apoptosis inducing agent; effects cell differentiation. ( CSP )] (UMLS (CSP) C0031465) =Organic Chemical =Acids, Carbocyclic;
butyrate;
phenylcarboxylate;
=PHENYLBUTYRATE |
- 23. Phenergan
- (UMLS (NCI) C0591971) =Organic Chemical; Pharmacologic Substance ;
| - 58. phenylcarboxylate
- [ ] (UMLS (CSP) C0597216) =Organic Chemical ;
=cyclic acid;
=benzoate;
phenylacetate;
phenylbutyrate |
- 24. PHENINDIONE
- [An indandione that has been used as an anticoagulant. Phenindione has actions similar to WARFARIN, but it is now rarely employed because of its higher incidence of severe adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p234) ( MSH )] (UMLS (NCI) C0031406) =Organic Chemical; Pharmacologic Substance ;
=Indans;
=1,3-Indandione, 2-(p-methoxyphenyl)- | - 59. phenylenediamine
- [ ] (UMLS (CSP) C0031468) =Organic Chemical; Pharmacologic Substance ;
|
- 25. PHENIRAMINE
- [One of the HISTAMINE H1 ANTAGONISTS with little sedative action. It is used in treatment of hay fever, rhinitis, allergic dermatoses, and pruritus. ( MSH )] (UMLS (NCI) C0031408) =Organic Chemical; Pharmacologic Substance ;
=pyridine;
[AH400] ANTIHISTAMINES, ALKYLAMINE =BROMPHENIRAMINE;
chlorphenamine;
PHENIRAMINE MALEATE | - 60. PHENYLEPHRINE
- [direct acting sympathomimetic amine that stimulates alpha-adrenergic receptors and is a powerful vasoconstrictor. ( CSP )] (UMLS (NCI) C0031469) =Organic Chemical; Pharmacologic Substance ;
=adrenergic agent;
Ethanolamines;
[NT100] DECONGESTANTS, NASAL;
phenolic amine;
[AU100] SYMPATHOMIMETICS (ADRENERGICS);
[OP600] MYDRIATICS/CYCLOPLEGICS, TOPICAL OPHTHALMIC;
[RS201] HEMORRHOIDAL PREPARATIONS WITHOUT STEROID;
=PHENYLEPHRINE HYDROCHLORIDE;
Phenylephrine Bitartrate;
PHENYLEPHRINE TANNATE;
PHENYLEPHRINE HYDROCHLORIDE;
Phenylephrine Bitartrate;
PHENYLEPHRINE TANNATE;
PHENYLEPHRINE 5 MG;
Phenylephrine 0.4 MG/ML;
|
- 26. PHENMETRAZINE
- [A sympathomimetic drug used primarily as an appetite depressant. Its actions and mechanisms are similar to DEXTROAMPHETAMINE. ( MSH )] (UMLS (NCI) C0031411) =Organic Chemical; Pharmacologic Substance ;
=morpholine;
[GA751] CENTRALLY-ACTING APPETITE SUPPRESSANTS =PHENMETRAZINE HYDROCHLORIDE | - 61. Phenylephrine Bitartrate
- [The bitartrate salt form of phenylephrine, a direct-acting sympathomimetic amine chemically related to adrenaline and ephedrine with potent vasoconstricting activity. Phenylephrine is a post-synaptic alpha-adrenergic receptor agonist that causes vasoconstriction, increases systolic/diastolic pressures, reflex bradycardia, and increases stroke output. ( NCI )] (UMLS (NCI) C0304428) =Organic Chemical; Pharmacologic Substance =PHENYLEPHRINE;
TO BE DELETED INGREDIENT PREPARATIONS |
- 27. Phenocopy
- [An environmentally produced phenotype simulating the effect of a particular genotype. ( NCI )] (UMLS (NCI) C0678921) =Organism Attribute ;
| - 62. Phenylephrine/Phenylpropanolamine/Guaifenesin
- [A combination preparation containing phenylephrine, phenylpropanolamine and guaifenesin with decongestant and expectorant activities. Phenylephrine and phenylpropanolamine, direct-acting sympathicomimetic amines, activate alpha-adrenergic receptors in the nasal mucosa thereby causing vasoconstriction, reduces swelling of nasal mucous membranes and decreasing nasal and sinus congestion. Phenylpropanolamine also releases norepinephrine from its storage sites resulting in the effects already described. Guaifenesin increases respiratory tract mucus secretions and reduces the viscosity of mucus secretion by reducing adhesiveness and surface tension as well as increasing hydration of mucus, thereby increasing the efficiency of removing accumulated secretions from the upper and lower airways and making cough more productive. ( NCI )] (UMLS (NCI) C1445789) =Organic Chemical; Pharmacologic Substance
|
- 28. phenol
- [any organic compound containing one or more hydroxyl groups attached to a benzene ring. ( CSP )] (UMLS (CSP) C0031428) =Organic Chemical =Organic Chemical;
cyclic alcohol =2,6-Bis(1,1-dimethylethyl)-4-methylphenol;
catechol;
1,4 benzenediol;
nitrophenol;
phenolic amine;
Anisoles;
catechol;
Chlorophenols;
Cresols;
DIENESTROL;
Hydroquinones;
Hydroxybenzoic Acids;
Phenolphthaleins;
PROBUCOL;
PROPOFOL;
Pyrogallol;
Resorcinols;
2,4,6-tribromophenol;
Phenol | - 63. phenylethanol
- [An antimicrobial, antiseptic, and disinfectant that is used also as an aromatic essence and preservative in pharmaceutics and perfumery. ( MSH )] (UMLS (CSP) C0031398) =Organic Chemical; Pharmacologic Substance ;
|
- 29. Phenol
- [Hydroxybenzene; Carbolic Acid. Used as a germicidal agent and as an intermediate in chemical synthesis. Highly toxic; corrosive to the skin. ( NCI )] (UMLS (HL7) C0070570) =Organic Chemical; Pharmacologic Substance ;
=phenol;
[NT300] ANESTHETICS, MUCOSAL;
[PH000] PHARMACEUTICAL AIDS / REAGENTS;
Additive/Preservative =PHENOL,LIQUIFIED;
MENTHOL/PHENOL;
PHENOL LIQUID (ML);
Atropine 0.14 MG/ML / Edrophonium 10 MG/ML Injectable Solution;
BENZOCAINE/PHENOL/VITAMIN E/ZINC OXIDE OINT,TOP;
CAMPHOR/EUCALYPTUS/MENTHOL/PHENOL LOTION;
MASSENGILL DOUCHE POWDER,VAG;
GLYCERIN/MINERAL OIL/PHENOL LIQUID,TOP;
LANABURN OINT,TOP;
CARMEX OINT,TOP;
PHENOL 0.1 %;
PHENOL 0.25 %;
PHENOL 0.3 %;
PHENOL 0.42 %;
PHENOL 1.4 %;
PHENOL 2.8 MG/0.7ML;
PHENOL 24.2 %;
PHENOL 3 MG/ML;
PHENOL 3.3 MG/ML;
PHENOL 4.5 %;
PHENOL 0.4 %;
PHENOL 0.5 %;
PHENOL 1.45 %;
PHENOL 3 %;
PHENOL 0.72 %;
PHENOL 4.5 GM;
PHENOL 68.75 %;
PHENOL 4.7 %;
PHENOL 1 % | - 64. phenylmethylamine
- [ ] (UMLS (CSP) C0031492) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
|
- 30. Phenol
- [Phenol. Urine preservative ( HL7V3.0 )] (UMLS (HL7) C1556058) =Intellectual Product =MaterialEntityAdditive;
| - 65. PHENYLPROPANOLAMINE
- [An alpha- and beta-adrenergic receptor agonist with sympathomimetic activity. Phenylpropanolamine (PPA) binds to and activates alpha- and beta-adrenergic receptors in the mucosa of the respiratory tract resulting in vasoconstriction and reduction in swelling of nasal mucous membranes and reduction in tissue hyperemia, edema, and nasal congestion. This agent also stimulates the release of norepinephrine from its storage sites resulting in the effects already described. Finally, PPA indirectly stimulates beta-receptors producing tachycardia and a positive inotropic effect. ( NCI )] (UMLS (NCI) C0031495) =Organic Chemical; Pharmacologic Substance =Propanolamines;
[RE200] DECONGESTANTS, SYSTEMIC =PHENYLPROPANOLAMINE HYDROCHLORIDE;
METARAMINOL;
PHENYLPROPANOLAMINE HYDROCHLORIDE |
- 31. phenolase
- [ ] (UMLS (CSP) C0598897) =Amino Acid, Peptide, or Protein; Enzyme
| - 66. phenylpyruvic oligophrenia
- [ ] (UMLS (CSP) C0751434) =Disease or Syndrome
|
- 32. phenolate
- [ ] (UMLS (CSP) C0597206) =Organic Chemical ;
| - 67. phenylsulfonamide
- [ ] (UMLS (CSP) C0597978) =Organic Chemical ;
|
- 33. phenolic amine
- [ ] (UMLS (CSP) C0597207) =Organic Chemical ;
=phenol;
phenylalkylamine =catecholamine;
octopamine;
PHENYLEPHRINE;
tyramine;
| - 68. pheromone
- [substance secreted to the outside of the body by an individual and perceived (as by smell) by a second individual of the same species, prompting a specific behavioral reaction in the perceiver. ( CSP )] (UMLS (CSP) C0031516) =Biologically Active Substance ;
=Endocrine Gland Secretion;
|
- 34. Phenolphthalein
- [An organic compound used as a laboratory reagent and pH indicator. Phenolphthalein exerts laxative effects by stimulating the intestinal mucosa and constricting smooth muscles. However, phenolphthalein is no longer used as a laxative due to the suspected carcinogenicity of this compound. ( NCI )] (UMLS (NCI) C0600489) =Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid =Phenolphthaleins;
[GA204] STIMULANT LAXATIVES;
Phenolphthalein;
Inactive Ingredient Preparations =Phenolphthalein;
PHENOLPHTHALEIN,YELLOW;
Phenolphthalein 10 MG/ML;
PHENOLPHTHALEIN 120 MG;
PHENOLPHTHALEIN 64.8 MG;
PHENOLPHTHALEIN 65 MG;
PHENOLPHTHALEIN 80 MG;
Phenolphthalein 13.4 MG/ML;
PHENOLPHTHALEIN TAB 130 MG X 2;
PHENOLPHTHALEIN,WHITE 130 MG;
PHENOLPHTHALEIN,WHITE 60 MG | - 69. pheromone detector
- [ ] (UMLS (CSP) C0599626) =Body System
|
- 35. Phenomenon, Raynauds
- [Intermittent bilateral attacks of ischemia of the fingers or toes and sometimes of the ears or nose, marked by severe pallor, and often accompanied by paresthesia and pain. ( NCI )] (UMLS (NCI) C0034735) =Disease or Syndrome
| - 70. Phetharbital
- [A short-acting barbiturate derivative without hypnotic properties, Phetharbital (N-phenylbarbital) can be used as a sedative and anticonvulsant agent due to its mechanism of enhancing GABA (Gamma Amino Butyric Acid) transmission and inhibition of synaptic excitation. Phetharbital has generally been withdrawn from clinical use. (NCI04) ( NCI )] (UMLS (NCI) C0070722) =Organic Chemical; Pharmacologic Substance ;
|
home
